Vertex Pharmaceuticals (VRTX)

Add to Watchlists Create an Alert
78.29 -0.14  -0.18%   NASDAQ May 23, 4:58PM BATS Real time Currency in USD

Vertex Pharmaceuticals Cash from Operations TTM:

199.15M for March 31, 2013
View Full Chart

Vertex Pharmaceuticals Cash from Operations TTM Chart

    Vertex Pharmaceuticals Historical Cash from Operations TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 199.15M
    Dec. 31, 2012 267.84M
    Sept. 30, 2012 730.94M
    June 30, 2012 667.88M
    March 31, 2012 333.28M
    Dec. 31, 2011 143.74M
    Sept. 30, 2011 -526.03M
    June 30, 2011 -732.92M
    March 31, 2011 -625.61M
    Dec. 31, 2010 -635.44M
    Sept. 30, 2010 -571.67M
    June 30, 2010 -429.31M
    March 31, 2010 -438.49M
    Dec. 31, 2009 -427.59M
    Sept. 30, 2009 -422.48M
    June 30, 2009 -528.33M
    March 31, 2009 -306.51M
    Dec. 31, 2008 -226.48M
    Sept. 30, 2008 -181.95M
    June 30, 2008 -118.11M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Operations (TTM)

    Definition: Cash from Operations

    Learn More

    Get data for

    VRTX Cash from Operations TTM Benchmarks

    Companies
    Cleveland BioLabs -20.65M
    Gilead Sciences 3.195B
    Merck 10.02B

    VRTX Cash from Operations TTM Rankings

    Overall 85th percentile
    1131 of 8006
    Sector 86th percentile
    92 of 686 in Healthcare
    Industry 95th percentile
    11 of 248 in Biotechnology

    VRTX Cash from Operations TTM Range, Past 5 Years

    Minimum -732.92M Jun 2011
    Maximum 730.95M Sep 2012
    Average -191.40M